LINC00240 and esophageal squamous cell carcinoma: Experimental data have shown that LINC00240 and LOXL2 possibly compete for miR-26b-5p binding [14], and overexpression of miR-26b-5p served as a poor prognostic marker in the subtype 2 of ESCC.